Abstract:The low FODMAP (fermentable oligosaccharide, disaccharide, monosaccharide, and polyol) diet is a beneficial therapeutic approach for patients with irritable bowel syndrome (IBS). However, how the low FODMAP diet works is still not completely understood. These mechanisms encompass not only traditionally known factors such as luminal distension induced by gas and water but also recent evidence on the role of FOMAPs in the modulation of visceral hypersensitivity, increases in intestinal permeability, the induction of microbiota changes, and the production of short-chain fatty acids (SCFAs), as well as metabolomics and alterations in motility. Although most of the supporting evidence is of low quality, recent trials have confirmed its effectiveness, even though the majority of the evidence pertains only to the restriction phase and its effectiveness in relieving abdominal bloating and pain. This review examines potential pathophysiological mechanisms and provides an overview of the existing evidence on the effectiveness of the low FODMAP diet across various IBS subtypes. Key considerations for its use include the challenges and disadvantages associated with its practical implementation, including the need for professional guidance, variations in individual responses, concerns related to microbiota, nutritional deficiencies, the development of constipation, the necessity of excluding an eating disorder before commencing the diet, and the scarcity of long-term data. Despite its recognized efficacy in symptom management, acknowledging these limitations becomes imperative for a nuanced comprehension of the role of a low FODMAP diet in managing IBS. By investigating its potential mechanisms and evidence across IBS subtypes and addressing emerging modulations alongside limitations, this review aims to serve as a valuable resource for healthcare practitioners, researchers, and patients navigating the intricate landscape of IBS.

Dietary management of irritable bowel syndrome: considerations, challenges, and solutions

The role of diet in the pathophysiology and management of irritable bowel syndrome

The Role of Food in the Treatment of Bowel Disorders: Focus on Irritable Bowel Syndrome and Functional Constipation

Diet-microbiota interaction in irritable bowel syndrome: looking beyond the low-FODMAP approach

Efficacy of the low FODMAP diet for treating irritable bowel syndrome: the evidence to date

Popular diets and nutritional assessment in the management of irritable bowel syndrome in inflammatory bowel disease: an overview of current evidence

The low-FODMAP diet for irritable bowel syndrome: Lights and shadows

A personalized management approach in disorders of the irritable bowel syndrome spectrum

Current state of the non‐pharmacological management of irritable bowel syndrome: an up‐to‐date review of the literature

[Contemporary dietotherapy of the irritable bowel syndrome]

The low FODMAP diet in clinical practice: where are we and what are the long-term considerations?

The Effect of Polyphenols, Minerals, Fibers, and Fruits on Irritable Bowel Syndrome: A Systematic Review

The Role of the FODMAP Diet in IBS

The low FODMAP diet: recent advances in understanding its mechanisms and efficacy in IBS

Diet, fibers, and probiotics for irritable bowel syndrome

Irritable bowel syndrome and mental health comorbidity — approach to multidisciplinary management

The Irritable Bowel Syndrome: Mechanisms and a Practical Approach to Management

Dietary fiber in irritable bowel syndrome (Review)

Review article: Evidence‐based dietary management of inflammatory bowel disease

Food Intolerances, Food Allergies and IBS: Lights and Shadows

Gut Microbial Metabolites and Biochemical Pathways Involved in Irritable Bowel Syndrome: Effects of Diet and Nutrition on the Microbiome